ARG63002

anti-HIV protease antibody [1696]

anti-HIV protease antibody [1696] for ELISA,Functional study,Western blot and HIV

Immune System antibody; Microbiology and Infectious Disease antibody

Overview

Product Description

Mouse Monoclonal antibody [1696] recognizes HIV protease

Tested Reactivity HIV
Tested Application ELISA, FuncSt, WB
Specificity The clone 1696 recognizes free N-terminus of mature HIV protease (HIV-1 and HIV-2), an enzyme that hydrolyzes polyproteins of HIV viruses into functional proteins.
1696 does not react with the precursor.
Host Mouse
Clonality Monoclonal
Clone 1696
Isotype IgG1
Target Name HIV protease
Antigen Species HIV
Immunogen Bacterially expressed full-length HIV-1 protease
Conjugation Un-conjugated

Application Instructions

Application Suggestion
Tested Application Dilution
ELISAAssay-dependent
FuncStAssay-dependent
WB0.5 µg/ml
Application Note Functional studies: The clone 1696 strongly inhibits the enzyme activity of HIV-1 and HIV-2 proteases.
* The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Purified from ascites by protein-A affinity chromatography.
Purity > 95% (by SDS-PAGE)
Buffer PBS (pH 7.4) and 15 mM Sodium azide
Preservative 15 mM Sodium azide
Concentration 1 mg/ml
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Background The HIV protease (PR) hydrolyzes polyproteins of HIV virus into functional protein products that are essential for its assembly and subsequent activity. This maturation process occurs as the virion buds from the host cell.
HIV protease inhibitors are used in the treatment of patients with AIDS and were considered the first breakthrough in over a decade of AIDS research. HIV protease inhibitors can lower the viral load carried by AIDS patients.
Research Area Immune System antibody; Microbiology and Infectious Disease antibody

Images (1) Click the Picture to Zoom In

  • ARG63002 anti-HIV protease antibody [1696] Dot Blot image

    Dot Blot: 1. Recombinant HIV protease (0.2 µg/ml) 2. Recombinant HIV protease (1.0 µg/ml) 3. Recombinant HIV protease (2.0 µg/ml) stained with ARG63002 anti-HIV protease antibody [1696].

Clone References

Diversification and specialization of HIV protease function during in vitro evolution.

WB / 

O'Loughlin TL et al.
Mol Biol Evol.,  (2006)

publication_link

 

hr_line

Inhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibody.

Lescar J et al.
Protein Sci.,  (1999)

publication_link

 

hr_line